(34 days)
No
The summary describes a telemedicine system for data collection and communication, with no mention of AI or ML capabilities for data analysis or interpretation.
No
The device is described as a "communication tool" and a "PC based Telemedicine system" for acquiring, accumulating, and transmitting patient data to a healthcare practitioner for review. It explicitly states that "Decisions concerning diagnosis and treatment are to be performed by qualified healthcare professionals," indicating that the device itself does not provide therapy or treatment.
No
The device description states its intention as a communication tool for collecting and transmitting patient data to a remote practitioner for review. It explicitly notes that "Decisions concerning diagnosis and treatment are to be performed by qualified healthcare professionals," indicating that the device itself does not perform diagnostic functions.
No
The device description explicitly states it is a "PC based Telemedicine system" and mentions acquiring, accumulating, and transmitting vital signs information, which implies the use of hardware components for data acquisition (e.g., sensors, monitoring devices). While software is a key part of the system, it is not described as a standalone software-only device.
Based on the provided information, the ViTelCare™ C-Turtle Patient Monitoring System is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The ViTelCare™ C-Turtle system is described as a communication tool that collects, accumulates, and transmits vital signs and other physiological data from the patient to a healthcare practitioner. It facilitates remote monitoring and communication.
- Lack of Sample Analysis: There is no mention of the device analyzing biological samples or performing any tests on samples taken from the patient's body.
- Focus on Data Transmission and Communication: The primary function is the transmission and review of patient data and communication between the patient and healthcare professional.
The device falls under the category of patient monitoring and telemedicine systems, which are distinct from in vitro diagnostics.
N/A
Intended Use / Indications for Use
ViTelCare™ C-Turtle Patient Monitoring System is intended to be a communication tool for an in-home patient that acquires, accumulates, and transmits vital signs information, self-assessment of physical condition, and other physiological data to a healthcare practitioner located remotely from the patient. The patient information is received and stored on the MedVizer™ ViTelCare Call Center where a qualified healthcare practitioner can review the patient information and data. The healthcare practitioner can contact the patient directly through a videoconference connection when desired. The communication connectivity between patient and healthcare practitioner is via a standard public telecommunications utility to the Internet. Decisions concerning diagnosis and treatment are to be performed by qualified healthcare professionals.
Product codes
MWI
Device Description
The ViTelCare™ C-Turtle Patient Monitoring System is a PC based Telemedicine system adapted to the collection, management, and communication of patient monitoring data from home and group care environments.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
healthcare practitioner located remotely from the patient / in-home patient and group care environments
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Substantial Equivalence to Predicate Device: The ViTelCare™ C-Turtle Patient Monitoring System is virtually identical to the ViTelCare™ Turtle 400 Monitoring System with addition of videoconference functionality of the Turtle 800. There are no technical differences with any implications for safety and effectiveness. The labeling of ViTelCare™ C-Turtle Patient Monitoring System includes extensive protocols for monitoring patients with medical conditions. These have been derived from guidelines published by the VA, DoD, and other national organizations.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
ViTelCare™ Patient Monitoring System (K040581), ViTelCare™ Turtle 800 Patient Monitoring System (C040283), ViTelCare™ Turtle 400 Patient Monitoring System (K043368)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
Attachment F
APR 13 2006
510(k) Summary As Required by 807.92 For ViTelCare™ C-Turtle Patient Monitoring System Prepared on March 9th, 2006
| Submitted By: | ViTel Net
8201 Greensboro Drive, Suite 600
McLean, VA 22102 |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Tel. (703) 448-0999 | Fax: (703) 749-9559 |
| Contact Person: | Allen Izadpanah
President and Chief Executive Officer |
| Device Trade Name: | ViTelCare™ C-Turtle Patient Monitoring System |
| Common Name: | C-Turtle Patient Monitoring System |
| Classification: | Not Classified |
| Predictive Device: | ViTelCare™ Patient Monitoring System (K040581)
ViTelCare™ Turtle 800 Patient Monitoring System
(C040283)
ViTelCare™ Turtle 400 Patient Monitoring System
(K043368) |
| Manufactured By: | ViTel Net
221 Elizabeth Street
Utica, NY 13501 |
Description of The Device: The ViTelCare™ C-Turtle Patient Monitoring System is a PC based Telemedicine system adapted to the collection, management, and communication of patient monitoring data from home and group care environments.
Intended Use For This Device: Indications for Use: ViTelCare™ C-Turtle Patient Monitoring System is intended to be a communication tool for an in-home patient that acquires, accumulates, and transmits vital signs information, self-assessment of physical condition, and other physiological data to a healthcare practitioner located remotely from the patient. The patient information is received and stored on the MedVizer™ ViTelCare Call Center where a qualified healthcare practitioner can review the patient information and data. The healthcare practitioner can contact the patient directly through a videoconference connection when desired. The communication connectivity between
ViTel Net 16 March 2006
page 1 of 2
1
KokoTin page 2
patient and healthcare practitioner is via a standard public telecommunications utility to the Internet. Decisions concerning diagnosis and treatment are to be performed by qualified healthcare professionals.
Substantial Equivalence to Predicate Device: The ViTelCare™ C-Turtle Patient Monitoring System is virtually identical to the ViTelCare™ Turtle 400 Monitoring System with addition of videoconference functionality of the Turtle 800. There are no technical differences with any implications for safety and effectiveness. The labeling of ViTelCare™ C-Turtle Patient Monitoring System includes extensive protocols for monitoring patients with medical conditions. These have been derived from guidelines published by the VA, DoD, and other national organizations.
2
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 1 9 2006
ViTel Net c/o Mr. Allen Izadpanah President and Chief Executive Officer 8201 Greensboro Drive, Suite 600 McLean, VA 22102
Re: K060712
Trade Name: ViTelCare™ C-Turtle Patient Monitoring System Regulation Number: 21 CFR 870.2300 Regulation Name: Physiological Patient Monitor (without arrhythmia detection or alarms) Regulatory Class: Class II (two) Product Code: MWI Dated: March 16. 2006 Received: March 16, 2005
Dear Mr. Izadpanah:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Allen Izadpanah
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.
Sincerely yours,
Bimemona for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Attachment B
Indications for Use
510(k) Number (if known): KO60712
Device Name: ViTelCare ™ C-Turtle Patient Monitoring System
Indications for Use: ViTelCare™ C-Turtle Patient Monitoring System is intended to be a communication tool for an in-home patient that acquires, accumulates, and transmits vital signs information, self-assessment of physical condition, and other physiological data to a healthcare practitioner located remotely from the patient. The patient information is received and stored on the MedVizer 114 ViTelCare Call Center where a qualified healthcare practitioner can review the patient information and data. The healtheare practitioner can contact the patient directly through a videoconference connection when desired. The communication connectivity between patient and healtheare practitioner is via a standard public telecommunications utility to the Internet. Decisions concerning diagnosis and treatment are to be performed by qualified healtheare professionals.
Prescription Use ____________ (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH. Office of Device Evaluation (ODE)
D'Annunzio
Page 1 of 1
Ville: No 16 Mach 11